| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/08/2009 | CN100475051C Phytase-containing animal food and method |
| 04/07/2009 | US7515977 Integrated configuration system for use in a process plant |
| 04/07/2009 | US7514593 Animal model for chronic obstructive pulmonary disease and cystic fibrosis |
| 04/07/2009 | US7514551 Multisignal labeling reagents, and processes and uses therefor |
| 04/07/2009 | US7514550 Sense and antisense regions; kits for gene silencing |
| 04/07/2009 | US7514549 Tumor inhibition by modulating sprouty expression or activity |
| 04/07/2009 | US7514548 Methods of inhibiting COX-2 |
| 04/07/2009 | US7514546 Antibodies |
| 04/07/2009 | US7514545 An isolated nucleotide sequence encoding a regulatory fusion protein consisting of modified ligand-binding domain of a human estrogen receptor and a transcription blocking domain comprising a mutated restriction enzyme capable of binding but not cleaving DNA |
| 04/07/2009 | US7514544 Expression vector comprising nucleotide sequences coding bacillus delta -endotoxin for use in transformation and generation of insect resistant corn |
| 04/07/2009 | US7514543 Immunoglobulin fusion for use as therapeutic tool in prevention and treatment of chronic progression of atherosclerosis in diabetic patients |
| 04/07/2009 | US7514542 Collagen-like protein CLAC, precursor thereof and genes encoding the same |
| 04/07/2009 | US7514532 Insulin-like growth factor polypeptide; for treating solid tumors having cells expressing IGFBP-3 receptors |
| 04/07/2009 | US7514530 Peptide carrier for delivering siRNA into mammalian cells |
| 04/07/2009 | US7514257 Transcription factor comprising zinc finger domain for use in controlling neuronal and osteoblast differentiation |
| 04/07/2009 | US7514253 Expression vector comprising nucleotide sequences coding orotate-phosphoribosyl transferase (URA-5) for use reporter tool in heterologous gene transfer; bioreactors |
| 04/07/2009 | US7514251 For production of methylated catechols; plant cell propagation |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514238 Growth factor homolog zvegf4 |
| 04/07/2009 | US7514236 genetically modified microorganism of the family of Actinomycetales of the Rhodococcus genus blocked in 3-ketosteroid 9 alpha -hydroxylase activity; useful in the microbial degradation of steroids to accumulate certain steroid products |
| 04/07/2009 | US7514222 polypeptides or proteins consisting of a four helix bundle formed of two dimerized helix-loop-helix motifs |
| 04/07/2009 | US7514220 Kits for detection of nucleic acids using invasive cleavage structures and flap endonucleases |
| 04/07/2009 | US7514219 a panel of differentially expressed genes used as biomarkers, for determining metastasis from the lungs, head or neck |
| 04/07/2009 | US7514218 Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction |
| 04/07/2009 | US7514215 Sulfotransferase SULT2A1 sequence variants |
| 04/07/2009 | US7514211 Nucleotide sequences comprising mutation associated with arthritic disorders; allelic variation, disease and gene therapy |
| 04/07/2009 | US7514210 Identifying and characterizing modulators of nucleic acid processing enzymes; enzyme inhibitors |
| 04/07/2009 | US7514209 Diagnosis and prognosis of breast cancer patients |
| 04/07/2009 | US7514207 Administering compound (antibodies, ATP analogs) that inhibits p-21 activated kinase (PAK) activity and/or merlin phosphorylation; drug screening; neurofibromatosis |
| 04/07/2009 | US7514110 Talaromyces xylanases |
| 04/07/2009 | US7514098 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 04/07/2009 | US7514089 Mutant Salmonella species with genetically engineered MSBB gene, expresses altered lipid, has reduced inductino of tumor necrosis factor and increased sensitivity to chelating agents; as antitumor agent |
| 04/07/2009 | US7514087 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 04/07/2009 | US7514078 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
| 04/07/2009 | CA2453382C Mannitol and glucitol derivatives |
| 04/07/2009 | CA2396113C Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 04/07/2009 | CA2242398C Nucleic acid molecules from plants coding enzymes which participate in the starch synthesis |
| 04/07/2009 | CA2207608C Isolation of nucleic acid |
| 04/07/2009 | CA2175332C Haemophilus transferrin receptor genes |
| 04/07/2009 | CA2100472C Inherited and somatic mutations of apc gene in colerectal cancer of humans |
| 04/02/2009 | WO2009042962A2 Antidotes for factor xa inhibitors and methods of using the same |
| 04/02/2009 | WO2009042910A2 Ship inhibition to direct hematopoietic stem cells and induce extramedullary hematopoiesis |
| 04/02/2009 | WO2009042680A2 Detection of mutations in acta2 and myh11 for assessing risk of vascular disease |
| 04/02/2009 | WO2009042504A1 Resistin antagonists and their use |
| 04/02/2009 | WO2009041831A1 PHAGE ϕMRU POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF |
| 04/02/2009 | WO2009039862A2 Enzymatic incorporation of lna nucleotides |
| 04/02/2009 | WO2009039657A1 High concentration chitosan-nucleic acid polyplex compositions |
| 04/02/2009 | WO2009039601A1 3.4 kb mitochondrial dna deletion for use in the detection of cancer |
| 04/02/2009 | WO2009021031A3 Proximity ligation assay |
| 04/02/2009 | WO2009018250A3 Use of rpa4 and rpa4/rpa32 hybrid polypeptides for modulating cell proliferation |
| 04/02/2009 | WO2008157696A3 High throughput nucleic acid sequencing by expansion |
| 04/02/2009 | WO2008109785A3 Hiv reverse transcriptase compositions and methods |
| 04/02/2009 | WO2008091283A3 Viral inhibitory nucleotide sequences and vaccines |
| 04/02/2009 | WO2008070144A3 Imprinted genes and disease |
| 04/02/2009 | WO2008066964A3 Compositions and methods for inducing or inhibiting activities of selected human cells |
| 04/02/2009 | WO2008051285A3 Methods and compositions for detecting fungi and mycotoxins |
| 04/02/2009 | WO2008028086A9 Methods and substances for isolation and detection of small polynucleotides |
| 04/02/2009 | WO2007046811A3 Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| 04/02/2009 | WO2006073627A3 Vaccinia virus nucleic acids, polypeptides, and immunogenic compositions |
| 04/02/2009 | WO2006060193A3 Compositions and methods for stem cell expansion |
| 04/02/2009 | WO2006052807A3 A dna molecule of mortierella alpina lpaat homolog |
| 04/02/2009 | WO2006023495A3 Carotenoid hydroxylase enzymes |
| 04/02/2009 | WO2005118797A3 Biosynthetic gene cluster for tautomycetin |
| 04/02/2009 | WO2005097169A3 Novel immunotherapy |
| 04/02/2009 | WO2005096805A3 Cambium/xylem-preferred promoters and uses thereof |
| 04/02/2009 | WO2005086900A3 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 04/02/2009 | WO2005084312A3 Disease control in shrimp |
| 04/02/2009 | WO2005081716A3 DNA VACCINES TARGETING ANTIGENS OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-CoV) |
| 04/02/2009 | WO2005076984A3 Thymidylate synthase gene and metastasis |
| 04/02/2009 | WO2005067632A3 Lipid compositions and use thereof |
| 04/02/2009 | WO2005062854A3 Polyamides for nucleic acid delivery |
| 04/02/2009 | WO2005054433A3 A novel “cleave-n-read” system for protease activity assay and methods of use thereof |
| 04/02/2009 | WO2005047477A3 Interspersed repetitive element rnas as substrates, inhibitors and delivery vehicles for rnai |
| 04/02/2009 | WO2005044974A3 Cell death-related nucleases and their uses |
| 04/02/2009 | WO2005044075A3 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 04/02/2009 | WO2005030930A3 Variants of cyan fluorescent protein with improved fluorescent properties |
| 04/02/2009 | WO2005023986A3 Microrna as ligands and target molecules |
| 04/02/2009 | WO2005019430A3 In vitro selection of aptamer beacons |
| 04/02/2009 | WO2005001060A3 Novel calcium channel |
| 04/02/2009 | WO2004110358A3 Polymeric conjugates for tissue activated drug delivery |
| 04/02/2009 | WO2004084453A3 METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES |
| 04/02/2009 | WO2003091420A9 Ribulose 1,5-bisphosphate carboxylase/oxygenase polypeptides and related polynucleotides |
| 04/02/2009 | WO2003087125A3 A novel g protein-coupled purinergic receptor, gave 17 |
| 04/02/2009 | US20090089901 Nucleic Acid Molecules and Other Molecules Associated with Plants |
| 04/02/2009 | US20090089897 Seed-Preferred Promoters |
| 04/02/2009 | US20090089896 Plant metabolite exporter gene promoters |
| 04/02/2009 | US20090089895 Antifungal polypeptides |
| 04/02/2009 | US20090089894 Metacaspase II in engineering soybean for disease resistance |
| 04/02/2009 | US20090089893 Sucrose synthase 3 promoter from rice and uses thereof |
| 04/02/2009 | US20090089891 Transcription factor stress-related proteins and methods of use in plants |
| 04/02/2009 | US20090089890 Methods and means for removal of a selected dna sequence |
| 04/02/2009 | US20090088982 Co-detection of single polypeptide and polynucleotide molecules |
| 04/02/2009 | US20090088563 Consisting of a sense and antisense region that form a duplex region; and from zero to one overhang regions; gene silencing, gene expression inhibition; gene therapy, drug discovery; cancer, Alzheimer's disease, diabetes |
| 04/02/2009 | US20090088562 Oligonucleotide analogs having cationic intersubunit linkages |
| 04/02/2009 | US20090088561 Enhancing the circulating half-life of antibody-based fusion proteins |
| 04/02/2009 | US20090088560 Process for Nucleic Acid Purification |
| 04/02/2009 | US20090088559 Method for preparing modified polypeptides |
| 04/02/2009 | US20090088555 44 Human Secreted Proteins |
| 04/02/2009 | US20090088398 Recombinant adenoviral vectors and methods of use |
| 04/02/2009 | US20090088365 Biosynthetic Polypeptide Fusion Inhibitors |